Factors predictive of complete resection of operable esophageal cancer: A prospective study

被引:80
作者
Mariette, C
Finzi, L
Fabre, S
Balon, JM
Van Seuningen, I
Triboulet, JPJ
机构
[1] CHRU, Serv Chirurg Digest, F-59037 Lille, France
[2] CHRU, Gen Hop Claude Huriez, F-59037 Lille, France
[3] CHRU, Unite 560, INSERM, F-59037 Lille, France
关键词
D O I
10.1016/S0003-4975(03)00172-3
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background. Esophagectomy remains a standard treatment for patients with resectable esophageal cancer, but the 5-year survival is only 20% to 25%. After complete resection survival is significantly longer than after incomplete resection with microscopic or macroscopic penetration. The purpose of this study was to prospectively identify the factors predictive of complete resection of operable esophageal cancers. Methods. Betwen January 1995 and January 2002, 372 patients with esophageal cancer underwent surgery with curative intent. Complete resection was performed in 304 patients (81.7%), incomplete resection with microscopic penetration in 28 (7.5%), and incomplete resection with macroscopic penetration in 40 (10.8%). Univariate and multivariate analysis included 16 preoperative and operative factors. Results. Factors predictive of complete resection were absence of any modification of the esophageal axis on the barium swallow (p = 0.019) and a partial or complete response to preoperative radiochemotherapy (p = 0.042). Three groups of patients were identified: group 1 had no deviation of the axis on the barium swallow (n = 253); group 2 had deviation of the axis on the barium swallow and partial or complete response to radiochemotherapy (n = 66); and group 3 had deviation of the axis on the barium swallow and no response to radiochemotherapy or no preoperative treatment (n = 53). Rates of complete resection were 90.1%, 74.2%, and 50.9%, and 5-year actuarial survivals were 46%, 37%, and 0%, respectively (p < 0.001). Conclusions. Complete resection of esophageal cancer is predictable. Deviation axis on the barium swallow and morphologic response to neoadjuvant radiochemotherapy are variables available for all patients at onset of therapeutic management. (Ann Thorac Surg 2003;75:1720-6) (C) 2003 by The Society of Thoracic Surgeons.
引用
收藏
页码:1720 / 1726
页数:7
相关论文
共 25 条
[1]
Ancona E, 2001, CANCER, V91, P2165, DOI 10.1002/1097-0142(20010601)91:11<2165::AID-CNCR1245>3.3.CO
[2]
2-8
[3]
Bancewicz J, 2002, LANCET, V359, P1727
[4]
Concurrent radiation therapy and chemotherapy followed by esophagectomy for localized esophageal carcinoma [J].
Bates, BA ;
Detterbeck, FC ;
Bernard, SA ;
Qaqish, BF ;
Tepper, JE .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) :156-163
[5]
Bedenne L, 1998, GASTROEN CLIN BIOL, V22, P273
[6]
Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus [J].
Bosset, JF ;
Gignoux, M ;
Triboulet, JP ;
Tiret, E ;
Mantion, G ;
Elias, D ;
Lozach, P ;
Ollier, JC ;
Pavy, JJ ;
Mercier, M ;
Sahmoud, T .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (03) :161-167
[7]
ELIAS D, 1993, GASTROEN CLIN BIOL, V17, P17
[8]
Multimodality therapy for resectable cancer of the thoracic esophagus [J].
Entwistle, JWC ;
Goldberg, M .
ANNALS OF THORACIC SURGERY, 2002, 73 (03) :1009-1015
[9]
Fink U, 1994, Ann Oncol, V5 Suppl 3, P17
[10]
PREOPERATIVE CHEMORADIATION FOLLOWED BY TRANSHIATAL ESOPHAGECTOMY FOR CARCINOMA OF THE ESOPHAGUS - FINAL REPORT [J].
FORASTIERE, AA ;
ORRINGER, MB ;
PEREZTAMAYO, C ;
URBA, SG ;
ZAHURAK, M .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1118-1123